Research article
Urinary N-acetyl-β-D glucosaminidase as a surrogate marker for renal function in autosomal dominant polycystic kidney disease: 1 year prospective cohort study
1 Department of Internal Medicine, Seoul National University College of Medicine, 101 Daehak-Ro Jongno-Gu, Seoul, 110-744, South Korea
2 Research Center for Rare Diseases, Seoul National University Hospital, Seoul, South Korea
3 Transplantation Center, Seoul National University Hospital, Seoul, South Korea
4 Department of Internal Medicine, Gacheon University Gil Hospital, Incheon, South Korea
5 Department of Radiology, Seoul National University College of Medicine, Seoul, South Korea
6 Department of Internal Medicine, Hallym University College of Medicine, Seoul, South Korea
7 Department of Pediatrics and Adolescent Medicine, Seoul National University College of Medicine, Seoul, South Korea
8 Kidney Research Institute, Seoul National University Hospital, Seoul, South Korea
9 Department of Internal Medicine, Eulji General Hospital, Eulji University 280-1 Hagye 1-dong, Nowon-gu, Seoul, 139-711, Korea
BMC Nephrology 2012, 13:93 doi:10.1186/1471-2369-13-93
Published: 30 August 2012Additional files
Additional file 1:
Patient distribution according to chronic kidney disease stages. The proportion of advanced CKD stages (IIIB and IV) increased as time passed.
Format: PDF Size: 46KB Download file
This file can be viewed with: Adobe Acrobat Reader
Additional file 2:
Linear regression analysis between the estimated glomerular filtration rate and total kidney volume. The TKV was negatively correlated with the estimated GFR (r2 = 0.334, P < 0.001).
Format: PDF Size: 48KB Download file
This file can be viewed with: Adobe Acrobat Reader
Additional file 3:
Urinary NAG/Cr according to chronic kidney disease stages. Patients in chronic kidney disease (CKD) stage III (estimated GFR < 60 mL/min/1.73 m2) showed significantly higher urinary NAG/Cr compared with CKD stage I or II (6.48 ± 3.79 vs. 3.7 ± 2.13 vs. 4.67 ± 2.47, P < 0.001).
Format: PDF Size: 29KB Download file
This file can be viewed with: Adobe Acrobat Reader
Additional file 4:
Repeated measurements of NAG/Cr could not predict renal function deterioration in 1 year. The patients were divided into three groups according to serial measurements of urinary NAG/Cr: persistently low NAG/Cr (<4.95 IU/g) (Group L-L), variable NAG/Cr (Group V), and persistently high NAG/Cr (≥4.95 IU/g) (Group H-H). Group H-H showed lower estimated GFRs at baseline (64.5 ± 23.3 mL/min/1.73 m2) and lower estimated GFR at 12 month (50.3 ± 18.5 mL/min/1.73 m2) compared to other groups (P < 0.001). Although statistically insignificant, the percentage decrement of estimated GFR over 12 months were greater in Group H-H compared to the other groups (Group H-H vs. Group V vs. Group L-L, -23.0% vs. -20.8% vs. -21.2%, P = 0.77).
Format: PDF Size: 155KB Download file
This file can be viewed with: Adobe Acrobat Reader
